TBA Law Blog


Posted by: Stacey Shrader Joslin on Feb 20, 2025

Tennessee Attorney General Jonathan Skrmetti this week led a 38-state and territory bipartisan coalition requesting that the Food and Drug Administration (FDA) take swift action against bad actors who are endangering consumers with counterfeit and unsafe forms of the GLP-1 weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound. The group is asking the FDA to lead efforts to safeguard the American supply chain and to work with other federal and state agencies to stop bad actors from producing counterfeit drugs. Read more in a news release from the attorney general office, read the full letter or view Tennessee’s GLP-1 warning.